• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of estrogen receptor isoforms and variants in breast cancer cell lines.乳腺癌细胞系中雌激素受体亚型及变体的分析
Exp Ther Med. 2011 May;2(3):537-544. doi: 10.3892/etm.2011.226. Epub 2011 Mar 10.
2
Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.雌激素受体(ER)亚型和ERβ同工型在结肠癌中的表达
Cancer Res. 2001 Jan 15;61(2):632-40.
3
Bisphenol AF as an activator of human estrogen receptor β1 (ERβ1) in breast cancer cell lines.双酚AF作为乳腺癌细胞系中人类雌激素受体β1(ERβ1)的激活剂。
J Toxicol Sci. 2018;43(5):321-327. doi: 10.2131/jts.43.321.
4
Reassessment of estrogen receptor expression in human breast cancer cell lines.人乳腺癌细胞系中雌激素受体表达的再评估。
Anticancer Res. 2011 Feb;31(2):521-7.
5
Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.卵巢癌中雌激素受体亚型和变体的差异表达:对细胞侵袭、增殖和预后的影响。
BMC Cancer. 2017 Aug 31;17(1):606. doi: 10.1186/s12885-017-3601-1.
6
ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups.雌激素受体β亚型在乳腺癌亚型和亚组中具有不同的临床意义。
Curr Issues Mol Biol. 2022 Apr 6;44(4):1564-1586. doi: 10.3390/cimb44040107.
7
Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.外显子7缺失变异体雌激素受体α蛋白在裸鼠体内生长的对雌二醇耐药、对他莫昔芬敏感的人子宫内膜腺癌中的作用。
Gynecol Oncol. 2002 Feb;84(2):271-9. doi: 10.1006/gyno.2001.6509.
8
Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.雌激素受体通向雌激素反应元件的途径:反式激活功能-1作为雌激素受体(ER)β介导的ERα转录抑制的关键要素。
J Steroid Biochem Mol Biol. 2007 May;104(3-5):110-22. doi: 10.1016/j.jsbmb.2007.03.002. Epub 2007 Mar 12.
9
Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas.乳腺癌中一种与雌激素受体表达呈负相关的基因(ICERE-1)的特征分析。
Eur J Biochem. 1998 Feb 15;252(1):169-77. doi: 10.1046/j.1432-1327.1998.2520169.x.
10
Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.转化生长因子β1和β2是人类乳腺癌细胞系的等效生长抑制剂。
J Cell Physiol. 1989 Nov;141(2):353-61. doi: 10.1002/jcp.1041410217.

引用本文的文献

1
Design, synthesis and biological evaluation of novel bis(indolyl)-tetrazine derivatives as anti-breast cancer agents.新型双(吲哚基)-四嗪衍生物作为抗乳腺癌药物的设计、合成及生物学评价
RSC Med Chem. 2025 Jul 23. doi: 10.1039/d5md00297d.
2
Long-Chain Fatty Acids Alter Estrogen Receptor Expression in Breast Cancer Cells.长链脂肪酸改变乳腺癌细胞中的雌激素受体表达。
Int J Mol Sci. 2025 Jul 13;26(14):6722. doi: 10.3390/ijms26146722.
3
Mechanism and Predictive Role of NUB1 Protein in Oestrogen Receptor Pathway of FEC-Treated Breast Cancer Patients.NUB1蛋白在FEC治疗的乳腺癌患者雌激素受体通路中的作用机制及预测作用
Biomedicines. 2025 May 27;13(6):1307. doi: 10.3390/biomedicines13061307.
4
dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation.dCas9-HDAC8-EGFP融合蛋白通过H3K9去乙酰化实现对乳腺癌细胞的表观遗传编辑。
Eur J Cell Biol. 2024 Dec;103(4):151463. doi: 10.1016/j.ejcb.2024.151463. Epub 2024 Oct 18.
5
Advancing Breast Cancer Therapeutics: Targeted Gene Delivery Systems Unveiling the Potential of Estrogen Receptor-Targeting Ligands.推进乳腺癌治疗:靶向基因递送系统揭示雌激素受体靶向配体的潜力。
Biomater Res. 2024 Sep 24;28:0087. doi: 10.34133/bmr.0087. eCollection 2024.
6
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs).孕激素受体在诱导多能干细胞(iPSCs)中持续表达。
Stem Cell Rev Rep. 2024 Nov;20(8):2303-2317. doi: 10.1007/s12015-024-10776-6. Epub 2024 Aug 22.
7
Double Imprinted Nanoparticles for Sequential Membrane-to-Nuclear Drug Delivery.双重印迹纳米颗粒用于顺序的膜至核药物递送。
Adv Sci (Weinh). 2024 Sep;11(36):e2309976. doi: 10.1002/advs.202309976. Epub 2024 Jul 8.
8
All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.全反式维甲酸通过 H19 和端粒酶调节糖酵解:miR-let-7a 在雌激素受体阳性乳腺癌细胞中的作用。
BMC Cancer. 2024 May 21;24(1):615. doi: 10.1186/s12885-024-12379-3.
9
Isolation and Characterization of a Novel Mammary Adenocarcinoma, MCa-P1362, with Hormone Receptor Expression, Human Epidermal Growth Factor Receptor 2 Positivity, and Enrichment in Cancer and Mesenchymal Stem Cells.一种新型乳腺腺癌 MCa-P1362 的分离与鉴定,该肿瘤具有激素受体表达、人表皮生长因子受体 2 阳性,并富含癌症和间充质干细胞。
Am J Pathol. 2024 Jun;194(6):1137-1153. doi: 10.1016/j.ajpath.2024.02.013.
10
Design, synthesis, and evaluation of indole-based tetrazole derivatives as putative anti-breast cancer agents.基于吲哚的四唑衍生物作为潜在抗乳腺癌药物的设计、合成与评价
RSC Med Chem. 2024 Feb 19;15(4):1329-1347. doi: 10.1039/d3md00730h. eCollection 2024 Apr 24.

本文引用的文献

1
The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.雌激素受体-β变体表达在乳腺癌发生过程中的变化:雌激素受体-β2表达降低是乳腺癌发展的关键事件。
J Surg Oncol. 2006 May 1;93(6):504-10. doi: 10.1002/jso.20336.
2
Estrogen receptors alpha and beta in rat placenta: detection by RT-PCR, real time PCR and Western blotting.大鼠胎盘中的雌激素受体α和β:通过逆转录聚合酶链反应、实时聚合酶链反应和蛋白质免疫印迹法进行检测
Reprod Biol Endocrinol. 2006 Mar 28;4:13. doi: 10.1186/1477-7827-4-13.
3
Estrogen receptors and human disease.雌激素受体与人类疾病。
J Clin Invest. 2006 Mar;116(3):561-70. doi: 10.1172/JCI27987.
4
The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells.人雌激素受体α亚型hERα46拮抗hERα66对MCF7乳腺癌细胞的增殖影响。
Endocrinology. 2005 Dec;146(12):5474-84. doi: 10.1210/en.2005-0866. Epub 2005 Sep 8.
5
Estrogen receptor mutations in human disease.人类疾病中的雌激素受体突变。
Endocr Rev. 2004 Dec;25(6):869-98. doi: 10.1210/er.2003-0010.
6
Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.乳腺癌中选择性剪接的雌激素受体β转录本的表达模式改变
Cancer Lett. 2004 Nov 8;215(1):101-12. doi: 10.1016/j.canlet.2004.05.006.
7
Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.雌激素受体β(ERβ)水平而非其ERβcx变体有助于预测乳腺癌中他莫昔芬耐药性。
Clin Cancer Res. 2004 Sep 1;10(17):5769-76. doi: 10.1158/1078-0432.CCR-04-0389.
8
Plasma membrane estrogen receptors exist and functions as dimers.质膜雌激素受体以二聚体形式存在并发挥功能。
Mol Endocrinol. 2004 Dec;18(12):2854-65. doi: 10.1210/me.2004-0115. Epub 2004 Jul 1.
9
Expression of an estrogen receptor variant lacking exon 3 in derivatives of MCF-7 cells with acquired estrogen independence or tamoxifen resistance.在获得性雌激素非依赖性或他莫昔芬耐药的MCF-7细胞衍生物中缺乏外显子3的雌激素受体变体的表达。
J Mol Endocrinol. 2004 Jun;32(3):935-45. doi: 10.1677/jme.0.0320935.
10
Relevance of breast cancer cell lines as models for breast tumours: an update.乳腺癌细胞系作为乳腺肿瘤模型的相关性:最新进展
Breast Cancer Res Treat. 2004 Feb;83(3):249-89. doi: 10.1023/B:BREA.0000014042.54925.cc.

乳腺癌细胞系中雌激素受体亚型及变体的分析

Analysis of estrogen receptor isoforms and variants in breast cancer cell lines.

作者信息

Al-Bader Maie, Ford Christopher, Al-Ayadhy Bushra, Francis Issam

机构信息

Departments of Physiology.

出版信息

Exp Ther Med. 2011 May;2(3):537-544. doi: 10.3892/etm.2011.226. Epub 2011 Mar 10.

DOI:10.3892/etm.2011.226
PMID:22977537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3440683/
Abstract

In the present study, the expression of estrogen receptor (ER)α and ERβ isoforms in ER-positive (MCF7, T-47D and ZR-75-1) and ER-negative (MDA-MB-231, SK-BR-3, MDA-MB-453 and HCC1954) breast cancer cell lines was investigated. ERα mRNA was expressed in ER-positive and some ER-negative cell lines. ERα Δ3, Δ5 and Δ7 spliced variants were present in MCF7 and T-47D cells; ERα Δ5 and Δ7 spliced variants were detected in ZR-75-1 cells. MDA-MB-231 and HCC1954 cells expressed ERα Δ5 and Δ7 spliced variants. The ERβ1 variant was expressed in all of the cell lines and the ERβ2 variant in all of the ER-positive and some ER-negative cell lines (MDA-MB-231, MDA-MB-453 and SK-BR-3). MCF7, ZR-75-1, MDA-MB-453, HCC1954 and T-47D cells expressed ERβ5. All cell lines expressed an ERα 66-kDa protein band, and some expressed the truncated 42-kDa variant. ERβ1 was detected in all of the cell lines in addition to a 38-44 kDa variant. The results indicate that breast cancer cell lines widely used in research and reported as being ER-negative express ERα and/or ERβ mRNA and protein.

摘要

在本研究中,我们调查了雌激素受体(ER)α和ERβ亚型在雌激素受体阳性(MCF7、T-47D和ZR-75-1)及雌激素受体阴性(MDA-MB-231、SK-BR-3、MDA-MB-453和HCC1954)乳腺癌细胞系中的表达情况。ERα mRNA在雌激素受体阳性和部分雌激素受体阴性细胞系中表达。ERα Δ3、Δ5和Δ7剪接变体存在于MCF7和T-47D细胞中;在ZR-75-1细胞中检测到ERα Δ5和Δ7剪接变体。MDA-MB-231和HCC1954细胞表达ERα Δ5和Δ7剪接变体。ERβ1变体在所有细胞系中均有表达,ERβ2变体在所有雌激素受体阳性和部分雌激素受体阴性细胞系(MDA-MB-231、MDA-MB-453和SK-BR-3)中表达。MCF7、ZR-75-1、MDA-MB-453、HCC1954和T-47D细胞表达ERβ5。所有细胞系均表达一条66 kDa的ERα蛋白条带,部分细胞系还表达截短的42 kDa变体。除了38 - 44 kDa变体,在所有细胞系中均检测到ERβ1。结果表明,广泛用于研究且报道为雌激素受体阴性的乳腺癌细胞系表达ERα和/或ERβ mRNA及蛋白。